期刊文献+

肝衰竭患者并发肺曲霉病八例临床分析 被引量:3

Invasive pulmonary aspergillosis in 8 patients with liver failure
原文传递
导出
摘要 曲霉是自然界中广泛存在的真菌,当人体免疫功能降低时可发生危及生命的侵袭性肺曲霉病(Invasive pulmonary aspergillosis,IPA).IPA属于深部真菌感染,其早期临床表现不典型,诊断较为困难,容易引起误诊或漏诊,且该病预后较差,病死率极高[1-2].肝衰竭是临床常见的危重症之一,患者多免疫功能低下,加之皮质类固醇激素及广谱抗菌药物的使用,
出处 《中华临床感染病杂志》 CAS 2014年第5期455-457,共3页 Chinese Journal of Clinical Infectious Diseases
关键词 肝功能衰竭 侵袭性肺曲霉病 临床分析 Liver failure Invasive pulmonary aspergillosis Clinical analysis
  • 相关文献

参考文献13

  • 1Hardak E, Yigla M, AviviI, et al. Impact of PCR-based diagnosis of invasive pulmonary aspergillosis on clinical outcome [ J ]. Bone Marrow Transplant ,2009,44:595-599.
  • 2Segal BH. Medical progress: Aspergillosis [ J]. N Engl J Med, 2009, 360 : 1870-1884.
  • 3Meersseman W, Lagrou K, Maertens J, et al. Invasive aspergillosis in the intensive care unit[J]. Clin Infect Dis, 2007, 45:205-216.
  • 4中华医学会感染病学分会肝衰竭与人工肝学组,中华医学会肝病学分会重型肝病与人工肝学组.肝衰竭诊疗指南[J].中华肝脏病杂志,2006,14:643-646.
  • 5De Pauw B, Walsh TJ, Donnelly JP, et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group [ S ]. Clin Infect Dis, 2008, 46 : 1813-1821.
  • 6Herbrecht R, Natarajan-Am S, Letscher-Bru , et al. lnvasive pulmonary aspergillosis[ J]. Semin Respir Crit Care Med, 2004, 25 : 191-202.
  • 7金儿,徐志豪.侵袭性肺曲霉菌病的临床诊治进展[J].国际呼吸杂志,2007,27(5):359-361. 被引量:6
  • 8刘景院,徐云良,魏丽荣,王慧珠,宋丽红.肝衰竭合并侵袭性肺曲霉菌病的危险因素和胸部影像特征分析[J].中华实验和临床感染病杂志(电子版),2013,7(5):13-16. 被引量:5
  • 9Prodanovic H, Cracco C, Massard J, et al. Invasive pulmonary aspergillosis in patients with decompensated cirrhosis: case series [ J]. BMC Gastroenterol, 2007, 7: 2.
  • 10周俊英,孙惠.伏立康唑联合卡泊芬净成功治疗2例肝功能衰竭合并侵袭性肺曲霉菌病[J].中华肝脏病杂志,2014,22(3):239-240. 被引量:6

二级参考文献36

  • 1Liver Failure and Artificial Liver Group, Chinese Society of Infectious Diseases, Chinese Medical Association.肝衰竭诊疗指南[J].中华肝脏病杂志,2006,14(9):643-646. 被引量:830
  • 2Denning DW,Ribaud P, Milpied N, et al. Efficacy and safety of voriconazole in the treatment of acute invasive aspergillosis. Clin Infect Dis,2002,35 : 1273-1275.
  • 3Denning DW. Echinocandin antifungal drugs. Lancet, 2003,362:1142-1151.
  • 4Stone EA, Fung HB, Kirschenbaum HL. Caspofungin: an echinocandin antifungal agent. Clin Ther, 2002,24 : 351-377.
  • 5Pacetti SA, Gelone SP. Caspofungin acetate for treatment of invasive fungal infections. Ann Pharmacother, 2003,37 : 90-98.
  • 6Alexander BD,Perfect JR. Antifungal resistance trends towards the year 2000. Implications for therapy and new approaches.Drugs, 1997,54 : 657-678.
  • 7Sionov E, Segal E. Polyene and cytokine treatment of experimental aspergillosis. FEMS Immunol Med Microbiol,2003,39 : 221-227.
  • 8Mun M, Kohno T, Yamada S. Lobectomy under video-assisted thoraeoseopie surgery for pulmonary aspergillosis. Kyobu Geka,2002,55 : 544-548.
  • 9Williamson EC, Leeming JP, Palmer HM, et al. Diagnosis of invasive aspergillosis in bone marrow transplant recipients by polymerase chain reaction. Br J Haematol, 2000,108,132-139.
  • 10Bretagne S, Costa JM, Bart-Delabesse E, et al. Comparison of galactomannan antigen detection and competitive polymerase chain reaction for diagnosing invasive aspergillosis.Clin Infect Dis,1998,26:1407-1412.

共引文献20

同被引文献35

引证文献3

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部